$22.79 1.7%
ATRC Stock Price vs. AI Score (Last 150 days)
Data gathered: May 28

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Atricure

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.


Atricure
Price $22.79
Target Price Sign up
Volume 242,910
Market Cap $1.12B
Year Range $20.69 - $43.91
Dividend Yield 0%
Revenue per Employee $394,859
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24109M28M81M-13M-9.3M-0.280
Q4 '23107M27M80M-9.8M-5.7M-0.210
Q3 '2398M24M74M-9.1M-5.3M-0.200
Q2 '23101M24M77M-5.1M-1.8M-0.110
Q1 '2393M24M70M-6.5M-3.8M-0.230

Insider Transactions View All

Noznesky Justin J filed to sell 71,284 shares at $24.1.
May 3 '24
Noznesky Justin J filed to sell 72,784 shares at $30.4.
April 3 '24
Dahlquist Karl S. filed to sell 50,954 shares at $32.2.
March 20 '24
Noznesky Justin J filed to sell 74,284 shares at $36.7.
March 14 '24
Dahlquist Karl S. filed to sell 52,839 shares at $37.4.
March 7 '24

What is the Market Cap of Atricure?

The Market Cap of Atricure is $1.12B.

How Many People Work at Atricure?

As of our latest update, Atricure employed approximately 1,050 people worldwide. However, it's important to note that Atricure's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Atricure's revenue per employee?

$394,859. To calculate Atricure's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Atricure?

Currently, the price of one share of Atricure stock is $22.79.

How can I analyze the ATRC stock price chart for investment decisions?

The ATRC stock price chart above provides a comprehensive visual representation of Atricure's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Atricure shares. Our platform offers an up-to-date ATRC stock price chart, along with technical data analysis and alternative data insights.

Does ATRC offer dividends to its shareholders?

As of our latest update, Atricure (ATRC) does not offer dividends to its shareholders. Investors interested in Atricure should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Atricure?

Some of the similar stocks of Atricure are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.